{"id":"https://openalex.org/W4393065652","doi":"https://doi.org/10.1182/blood.2023021088","title":"The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis","display_name":"The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393065652","doi":"https://doi.org/10.1182/blood.2023021088","pmid":"https://pubmed.ncbi.nlm.nih.gov/38518105","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11251409"},"language":"en","primary_location":{"id":"doi:10.1182/blood.2023021088","doi":"https://doi.org/10.1182/blood.2023021088","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.2023021088","pdf_url":"https://ashpublications.org/blood/article-pdf/143/26/2735/2232846/blood_bld-2023-021088-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ashpublications.org/blood/article-pdf/143/26/2735/2232846/blood_bld-2023-021088-main.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070751228","display_name":"Lennart Lenk","orcid":"https://orcid.org/0000-0002-3916-7604","observed_orcids":["https://orcid.org/0000-0002-3916-7604"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Lennart Lenk","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":"https://orcid.org/0000-0002-3916-7604","affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070953467","display_name":"Ir\u00e8ne Baccelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Ir\u00e8ne Baccelli","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032987569","display_name":"Anna Laqua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anna Laqua","raw_affiliation_strings":["3Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050524381","display_name":"Julia Heymann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Heymann","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109694268","display_name":"Claas Reimer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claas Reimer","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042644506","display_name":"Anna Dietterle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anna Dietterle","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051542325","display_name":"Dorothee Winterberg","orcid":"https://orcid.org/0009-0009-9840-8074","observed_orcids":["https://orcid.org/0009-0009-9840-8074"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dorothee Winterberg","raw_affiliation_strings":["4Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109591004","display_name":"Caroline Mary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Mary","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024979556","display_name":"Fr\u00e9d\u00e9rique Corallo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9rique Corallo","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028129441","display_name":"Julien Taurelle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julien Taurelle","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082907187","display_name":"Emma Narbeburu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emma Narbeburu","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064397939","display_name":"St\u00e9phanie Neyton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Neyton","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093397828","display_name":"Myl\u00e8ne D\u00e9ram\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Myl\u00e8ne D\u00e9ram\u00e9","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011981371","display_name":"Sabrina Pengam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sabrina Pengam","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079690916","display_name":"Fotini Vogiatzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Fotini Vogiatzi","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008128025","display_name":"Beat C. Bornhauser","orcid":"https://orcid.org/0000-0003-2890-3191","observed_orcids":["https://orcid.org/0000-0003-2890-3191"]},"institutions":[{"id":"https://openalex.org/I4210128593","display_name":"University Children's Hospital Zurich","ror":"https://ror.org/035vb3h42","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210128593"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Beat Bornhauser","raw_affiliation_strings":["5Department of Pediatric Hematology/Oncology, University Children's Hospital, Zurich, Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-2890-3191","affiliations":[{"raw_affiliation_string":"5Department of Pediatric Hematology/Oncology, University Children's Hospital, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210128593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053567227","display_name":"Jean\u2010Pierre Bourquin","orcid":"https://orcid.org/0000-0001-6571-6227","observed_orcids":["https://orcid.org/0000-0001-6571-6227"]},"institutions":[{"id":"https://openalex.org/I4210128593","display_name":"University Children's Hospital Zurich","ror":"https://ror.org/035vb3h42","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210128593"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Bourquin","raw_affiliation_strings":["5Department of Pediatric Hematology/Oncology, University Children's Hospital, Zurich, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-6571-6227","affiliations":[{"raw_affiliation_string":"5Department of Pediatric Hematology/Oncology, University Children's Hospital, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210128593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080023449","display_name":"Simon Raffel","orcid":"https://orcid.org/0000-0003-4671-1097","observed_orcids":["https://orcid.org/0000-0003-4671-1097"]},"institutions":[{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simon Raffel","raw_affiliation_strings":["6Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany"],"raw_orcid":"https://orcid.org/0000-0003-4671-1097","affiliations":[{"raw_affiliation_string":"6Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I2802164966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054846854","display_name":"Vladyslava Dovhan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Vladyslava Dovhan","raw_affiliation_strings":["7Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019684451","display_name":"Thomas Sch\u00fcler","orcid":"https://orcid.org/0000-0002-0567-4827","observed_orcids":["https://orcid.org/0000-0002-0567-4827"]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Sch\u00fcler","raw_affiliation_strings":["8Institute of Molecular and Clinical Immunology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-0567-4827","affiliations":[{"raw_affiliation_string":"8Institute of Molecular and Clinical Immunology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022986622","display_name":"Gabriele Escherich","orcid":"https://orcid.org/0000-0003-2167-3805","observed_orcids":["https://orcid.org/0000-0003-2167-3805","https://orcid.org/0000-0003-3901-8745"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gabriele Escherich","raw_affiliation_strings":["9Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035786690","display_name":"Monique L. den Boer","orcid":"https://orcid.org/0000-0002-5795-2921","observed_orcids":["https://orcid.org/0000-0002-5795-2921"]},"institutions":[{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Monique L. den Boer","raw_affiliation_strings":["10Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-5795-2921","affiliations":[{"raw_affiliation_string":"10Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016091450","display_name":"Judith M. Boer","orcid":"https://orcid.org/0000-0003-4848-7789","observed_orcids":["https://orcid.org/0000-0003-4848-7789"]},"institutions":[{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Judith M. Boer","raw_affiliation_strings":["10Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0003-4848-7789","affiliations":[{"raw_affiliation_string":"10Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111751795","display_name":"Wiebke We\u00dfels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wiebke Wessels","raw_affiliation_strings":["3Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012207265","display_name":"Matthias Peipp","orcid":"https://orcid.org/0000-0002-5088-3804","observed_orcids":["https://orcid.org/0000-0002-5088-3804"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias Peipp","raw_affiliation_strings":["4Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":"https://orcid.org/0000-0002-5088-3804","affiliations":[{"raw_affiliation_string":"4Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019668881","display_name":"Julia Alten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Alten","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072206709","display_name":"\u017deljko Anti\u0107","orcid":"https://orcid.org/0000-0001-9398-2637","observed_orcids":["https://orcid.org/0000-0001-9398-2637"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"\u017deljko Anti\u0107","raw_affiliation_strings":["11Department of Human Genetics, Hannover Medical School, Hannover, Germany"],"raw_orcid":"https://orcid.org/0000-0001-9398-2637","affiliations":[{"raw_affiliation_string":"11Department of Human Genetics, Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102974585","display_name":"Anke Katharina Bergmann","orcid":"https://orcid.org/0000-0002-1367-2725","observed_orcids":["https://orcid.org/0000-0002-1367-2725"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anke K. Bergmann","raw_affiliation_strings":["11Department of Human Genetics, Hannover Medical School, Hannover, Germany"],"raw_orcid":"https://orcid.org/0000-0002-1367-2725","affiliations":[{"raw_affiliation_string":"11Department of Human Genetics, Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020812442","display_name":"Martin Schrappe","orcid":"https://orcid.org/0000-0003-0034-5845","observed_orcids":["https://orcid.org/0000-0003-0034-5845"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Schrappe","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0034-5845","affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039583258","display_name":"Gunnar Cario","orcid":"https://orcid.org/0000-0001-8396-0127","observed_orcids":["https://orcid.org/0000-0001-8396-0127"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gunnar Cario","raw_affiliation_strings":["1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075073484","display_name":"Monika Br\u00fcggemann","orcid":"https://orcid.org/0000-0001-5514-5010","observed_orcids":["https://orcid.org/0000-0001-5514-5010"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Monika Br\u00fcggemann","raw_affiliation_strings":["3Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048543389","display_name":"Nicolas Poirier","orcid":"https://orcid.org/0000-0003-2335-9385","observed_orcids":["https://orcid.org/0000-0003-2335-9385"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Poirier","raw_affiliation_strings":["2OSE Immunotherapeutics, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2OSE Immunotherapeutics, Nantes, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012603847","display_name":"Denis Martin Schewe","orcid":"https://orcid.org/0000-0002-1070-0217","observed_orcids":["https://orcid.org/0000-0002-1070-0217"]},"institutions":[{"id":"https://openalex.org/I95793202","display_name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","ror":"https://ror.org/00ggpsq73","country_code":"DE","type":"education","lineage":["https://openalex.org/I95793202"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Denis M. Schewe","raw_affiliation_strings":["7Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-1070-0217","affiliations":[{"raw_affiliation_string":"7Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany","institution_ids":["https://openalex.org/I95793202"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5012603847","https://openalex.org/A5070751228","https://openalex.org/A5070953467"],"corresponding_institution_ids":["https://openalex.org/I32021983","https://openalex.org/I4210101439","https://openalex.org/I95793202"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":5.5473,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.96656877,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"143","issue":"26","first_page":"2735","last_page":"2748"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cd127","display_name":"CD127","score":0.9380000233650208},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.8899999856948853},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8529999852180481},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9210000038146973},{"id":"https://openalex.org/keywords/relapsed-refractory-leukemia","display_name":"relapsed/refractory leukemia","score":0.9509999752044678},{"id":"https://openalex.org/keywords/high-risk-leukemia","display_name":"high-risk leukemia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9679999947547913},{"id":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"B-cell precursor acute lymphoblastic leukemia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C123982805","wikidata":"https://www.wikidata.org/wiki/Q6046964","display_name":"Interleukin-7 receptor","level":5,"score":0.7023705840110779},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.6512411236763},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6410017609596252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6110842227935791},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5373048186302185},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5200098156929016},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5045169591903687},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48794645071029663},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4403440058231354},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3412572145462036},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3384043872356415},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2549581527709961},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.234453022480011},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.09136071801185608},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010587","descriptor_name":"Phagocytosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020395","descriptor_name":"Receptors, Interleukin-7","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053699","descriptor_name":"Interleukin-7 Receptor alpha Subunit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1182/blood.2023021088","doi":"https://doi.org/10.1182/blood.2023021088","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.2023021088","pdf_url":"https://ashpublications.org/blood/article-pdf/143/26/2735/2232846/blood_bld-2023-021088-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:38518105","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38518105","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11251409","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11251409/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Text"},{"id":"pmh:oai:www.zora.uzh.ch:270079","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/270079/1/ZORA_270079.pdf","pdf_url":"https://www.zora.uzh.ch/id/eprint/270079/1/ZORA_270079.pdf","source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/227181","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/227181","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lenk, L., Baccelli, I., Laqua, A., Heymann, J., Reimer, C., Dietterle, A., Winterberg, D., Mary, C., Corallo, F., Taurelle, J., Narbeburu, E., Neyton, S., D\u00e9ram\u00e9, M., Pengam, S., Vogiatzi, F., Bornhauser, B., Bourquin, J.-P., Raffel, S., Dovhan, V., \u2026 et al. (2024). The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood, 143, 2735\u20132748. https://doi.org/10.1182/blood.2023021088","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-270079","doi":"https://doi.org/10.5167/uzh-270079","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-270079","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1182/blood.2023021088","doi":"https://doi.org/10.1182/blood.2023021088","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.2023021088","pdf_url":"https://ashpublications.org/blood/article-pdf/143/26/2735/2232846/blood_bld-2023-021088-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1971263922","display_name":null,"funder_award_id":"KFO 5010","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G3364986933","display_name":null,"funder_award_id":"KFO 5010/1","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"}],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4393065652.pdf","grobid_xml":"https://content.openalex.org/works/W4393065652.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W2081305632","https://openalex.org/W2087296000","https://openalex.org/W2096709475","https://openalex.org/W2103420336","https://openalex.org/W2116213411","https://openalex.org/W2131419863","https://openalex.org/W2135611522","https://openalex.org/W2158932180","https://openalex.org/W2334045973","https://openalex.org/W2529448842","https://openalex.org/W2578585563","https://openalex.org/W2584524963","https://openalex.org/W2586218563","https://openalex.org/W2590701310","https://openalex.org/W2612483493","https://openalex.org/W2736092259","https://openalex.org/W2770192040","https://openalex.org/W2791821033","https://openalex.org/W2794056739","https://openalex.org/W2794341976","https://openalex.org/W2889246099","https://openalex.org/W2889395887","https://openalex.org/W2895925712","https://openalex.org/W2909045315","https://openalex.org/W2915355467","https://openalex.org/W2922290452","https://openalex.org/W2959015712","https://openalex.org/W2969354818","https://openalex.org/W2971006194","https://openalex.org/W2973991018","https://openalex.org/W2988333020","https://openalex.org/W2990889969","https://openalex.org/W2991695207","https://openalex.org/W2996276910","https://openalex.org/W3030558382","https://openalex.org/W3037959615","https://openalex.org/W3083881843","https://openalex.org/W3125725318","https://openalex.org/W3158861843","https://openalex.org/W3163535355","https://openalex.org/W3168084241","https://openalex.org/W3175578557","https://openalex.org/W3195389767","https://openalex.org/W4200347162","https://openalex.org/W4210429572","https://openalex.org/W4224232004","https://openalex.org/W4225358750","https://openalex.org/W4280515355","https://openalex.org/W4281737563","https://openalex.org/W4285490775","https://openalex.org/W4319063669","https://openalex.org/W4362676602","https://openalex.org/W4387673320","https://openalex.org/W4392040693","https://openalex.org/W6796666404","https://openalex.org/W6851390415"],"related_works":["https://openalex.org/W4400069075","https://openalex.org/W4362595645","https://openalex.org/W4405044318","https://openalex.org/W4310108898","https://openalex.org/W2922290452","https://openalex.org/W3211716345","https://openalex.org/W2969354818","https://openalex.org/W2587132900","https://openalex.org/W2418034645","https://openalex.org/W2130869560"],"abstract_inverted_index":{"ABSTRACT:":[0],"Acute":[1],"lymphoblastic":[2],"leukemia":[3,140,215],"(ALL)":[4],"arises":[5],"from":[6],"the":[7,55,91,212],"uncontrolled":[8],"proliferation":[9],"of":[10,90,107,119,126,170,185,194,214,219,229],"B-cell":[11],"precursors":[12],"(BCP-ALL)":[13],"or":[14],"T":[15],"cells":[16,180],"(T-ALL).":[17],"Current":[18],"treatment":[19,218],"protocols":[20],"obtain":[21],"high":[22],"cure":[23],"rates":[24],"in":[25,39,48,63,74,99,116,122,133,156,168,201,222,247],"children":[26],"but":[27],"are":[28,35],"based":[29],"on":[30],"toxic":[31],"polychemotherapy.":[32,251],"Novel":[33],"therapies":[34],"urgently":[36],"needed,":[37],"especially":[38],"relapsed/refractory":[40],"(R/R)":[41],"disease,":[42],"high-risk":[43],"(HR)":[44],"leukemias":[45],"and":[46,128,138,144,192,211,231],"T-ALL,":[47],"which":[49],"immunotherapy":[50,68,121,240],"approaches":[51],"remain":[52],"scarce.":[53],"Although":[54],"interleukin-7":[56],"receptor":[57],"(IL-7R)":[58],"plays":[59],"a":[60,87,95,123,157,182,238],"pivotal":[61],"role":[62],"ALL":[64,108,179],"development,":[65],"no":[66],"IL-7R-targeting":[67],"has":[69],"yet":[70],"reached":[71],"clinical":[72],"application":[73],"ALL.":[75],"The":[76],"IL-7R\u03b1":[77],"chain":[78],"(CD127)-targeting":[79],"IgG4":[80],"antibody":[81],"lusvertikimab":[82],"(LUSV;":[83],"formerly":[84],"OSE-127)":[85],"is":[86],"full":[88],"antagonist":[89],"IL-7R":[92,189],"pathway,":[93],"showing":[94],"good":[96,232],"safety":[97,233],"profile":[98],"healthy":[100],"volunteers.":[101],"Here,":[102],"we":[103],"show":[104],"that":[105],"\u223c85%":[106],"cases":[109],"express":[110],"surface":[111],"CD127.":[112],"We":[113],"demonstrate":[114],"significant":[115],"vivo":[117],"efficacy":[118],"LUSV":[120,148,177,235],"heterogeneous":[124],"cohort":[125],"BCP-":[127],"T-ALL":[129],"patient-derived":[130],"xenografts":[131],"(PDX)":[132],"minimal":[134],"residual":[135],"disease":[136],"(MRD)":[137],"overt":[139],"models,":[141],"including":[142],"R/R":[143],"HR":[145],"leukemias.":[146],"Importantly,":[147],"was":[149],"particularly":[150,246],"effective":[151],"when":[152],"combined":[153],"with":[154,162,173,207,249],"polychemotherapy":[155],"phase":[158],"2-like":[159],"PDX":[160,220],"study":[161],"CD127high":[163],"samples":[164],"leading":[165],"to":[166],"MRD-negativity":[167],">50%":[169],"mice":[171],"treated":[172],"combination":[174,248],"therapy.":[175],"Mechanistically,":[176],"targeted":[178],"via":[181],"dual":[183,227],"mode":[184,228],"action":[186,230],"comprising":[187],"direct":[188],"antagonistic":[190],"activity":[191],"induction":[193],"macrophage-mediated":[195],"antibody-dependent":[196],"cellular":[197],"phagocytosis":[198],"(ADCP).":[199],"LUSV-mediated":[200],"vitro":[202],"ADCP":[203],"levels":[204,210],"significantly":[205],"correlated":[206],"CD127":[208],"expression":[209],"reduction":[213],"burden":[216],"upon":[217],"animals":[221],"vivo.":[223],"Altogether,":[224],"through":[225],"its":[226],"profile,":[234],"may":[236],"represent":[237],"novel":[239],"option":[241],"for":[242],"any":[243],"CD127+":[244],"ALL,":[245],"standard-of-care":[250]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-03-23T00:00:00"}